• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国深圳 2017 年淋球菌感染与耐药国际论坛会议录

Proceedings of the 2017 International Forum on Gonococcal Infections and Resistance in Shenzhen, China.

出版信息

Sex Transm Dis. 2018 Oct;45(10):e75-e79. doi: 10.1097/OLQ.0000000000000859.

DOI:10.1097/OLQ.0000000000000859
PMID:29664765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6759053/
Abstract

The 2017 International Forum on Gonococcal Infections and Resistance (2017 IFGIR) was held at Shenzhen, China from September 17, 2017, to September 19, 2017. The key objectives of the conference were to review and analyze the epidemiological profiles of gonococcal infections and antimicrobial resistance (AMR) at global, regional, and national levels; to share and discuss findings from ongoing and completed research studies; and to identify research needs to respond to the spread of gonococcal infections and AMR. The following contents were presented at the conference: global estimates of infections with Neisseria gonorrhoeae; global, regional and country status of gonococcal AMR; molecular techniques for predicting gonococcal AMR and the use of these technologies to enhance gonococcal AMR surveillance and clinical management; and updates on therapeutic approaches to gonococcal AMR.

摘要

2017 年淋球菌感染与耐药国际论坛(2017 IFGIR)于 2017 年 9 月 17 日至 19 日在中国深圳举行。会议的主要目标是审查和分析全球、区域和国家各级淋球菌感染和抗菌素耐药性(AMR)的流行病学特征;分享和讨论正在进行和已完成的研究结果;并确定研究需求,以应对淋球菌感染和 AMR 的传播。会议介绍了以下内容:淋病奈瑟菌感染的全球估计数;全球、区域和国家淋病 AMR 状况;预测淋球菌 AMR 的分子技术以及这些技术在增强淋球菌 AMR 监测和临床管理中的应用;以及治疗淋球菌 AMR 的最新方法。

相似文献

1
Proceedings of the 2017 International Forum on Gonococcal Infections and Resistance in Shenzhen, China.中国深圳 2017 年淋球菌感染与耐药国际论坛会议录
Sex Transm Dis. 2018 Oct;45(10):e75-e79. doi: 10.1097/OLQ.0000000000000859.
2
Integrated molecular, phenotypic and epidemiological surveillance of antimicrobial resistance in Neisseria gonorrhoeae in Germany.德国淋病奈瑟菌的抗菌药物耐药性的综合分子、表型和流行病学监测。
Int J Med Microbiol. 2024 Mar;314:151611. doi: 10.1016/j.ijmm.2024.151611. Epub 2024 Jan 29.
3
Strengthening Global Surveillance for Antimicrobial Drug-Resistant Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Program.加强淋病奈瑟菌对抗菌药物耐药性的全球监测:强化淋球菌抗菌药物监测计划。
Emerg Infect Dis. 2017 Oct;23(13):S47-52. doi: 10.3201/eid2313.170443.
4
Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013.2010 - 2013年白俄罗斯(东欧地区)淋病奈瑟菌的抗菌药物敏感性/耐药性及NG - MAST特征分析
BMC Infect Dis. 2015 Jan 31;15:29. doi: 10.1186/s12879-015-0755-9.
5
Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.俄罗斯淋球菌抗菌药物敏感性方案(RU-GASP)——2009 年至 2012 年期间淋病奈瑟菌的耐药性和 2011 年和 2012 年的 NG-MAST 基因型。
BMC Infect Dis. 2014 Jun 19;14:342. doi: 10.1186/1471-2334-14-342.
6
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.2009-2016 年,欧盟/欧洲经济区淋病奈瑟菌分离株的抗菌药物敏感性/耐药性与患者的性别、性取向和感染解剖部位的关系。
BMC Infect Dis. 2021 Mar 18;21(1):273. doi: 10.1186/s12879-021-05931-0.
7
Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.2012 - 2014年期间巴基斯坦卡拉奇淋病奈瑟菌的抗菌药物耐药性及多重抗原序列分型(NG - MAST)基因型
BMC Infect Dis. 2016 Jul 22;16:353. doi: 10.1186/s12879-016-1673-1.
8
First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China.中国关于淋病奈瑟菌对头孢曲松耐药性及分子流行病学的首次全国性研究。
J Antimicrob Chemother. 2016 Jan;71(1):92-9. doi: 10.1093/jac/dkv321. Epub 2015 Oct 15.
9
Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16.2015 - 2016年巴西淋病奈瑟菌的基因组流行病学:阐明淋球菌的抗菌药物耐药性及谱系/亚谱系
J Antimicrob Chemother. 2020 Nov 1;75(11):3163-3172. doi: 10.1093/jac/dkaa318.
10
Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study.欧洲范围内耐多药淋病奈瑟菌谱系的扩张和消除:一项基于基因组监测的研究。
Lancet Microbe. 2022 Jun;3(6):e452-e463. doi: 10.1016/S2666-5247(22)00044-1. Epub 2022 May 10.

引用本文的文献

1
Dissemination of Neisseria gonorrhoeae with decreased susceptibility to extended-spectrum cephalosporins in Southern China, 2021: a genome-wide surveillance from 20 cities.2021 年中国南方地区对扩展谱头孢菌素敏感性降低的淋病奈瑟菌的传播:来自 20 个城市的全基因组监测。
Ann Clin Microbiol Antimicrob. 2023 May 17;22(1):39. doi: 10.1186/s12941-023-00587-x.
2
Dissemination and genome analysis of high-level ceftriaxone-resistant 60.001 strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019.2016-2019 年广东省淋球菌耐药监测项目(GD-GASP)中高水平头孢曲松耐药 60.001 株的传播和基因组分析。
Emerg Microbes Infect. 2022 Dec;11(1):344-350. doi: 10.1080/22221751.2021.2011618.

本文引用的文献

1
Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016.淋病奈瑟菌对阿奇霉素和头孢曲松的敏感性:2013 年至 2016 年全国监测数据的回顾性研究。
PLoS Med. 2018 Feb 6;15(2):e1002499. doi: 10.1371/journal.pmed.1002499. eCollection 2018 Feb.
2
Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.澳大利亚北领地淋病奈瑟菌的分子抗菌药物耐药性监测
Emerg Infect Dis. 2017 Sep;23(9):1478-1485. doi: 10.3201/eid2309.170427.
3
Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.淋病奈瑟菌的抗菌药物耐药性:全球监测及国际合作行动呼吁
PLoS Med. 2017 Jul 7;14(7):e1002344. doi: 10.1371/journal.pmed.1002344. eCollection 2017 Jul.
4
Large Cluster of Neisseria meningitidis Urethritis in Columbus, Ohio, 2015.2015 年俄亥俄州哥伦布市大规模脑膜炎奈瑟菌尿道炎集群。
Clin Infect Dis. 2017 Jul 1;65(1):92-99. doi: 10.1093/cid/cix215.
5
Australian Gonococcal Surveillance Programme annual report, 2015.《2015年澳大利亚淋球菌监测计划年度报告》
Commun Dis Intell Q Rep. 2017 Mar 31;41(1):E. doi: 10.33321/cdi.2017.41.9.
6
Emergence of a new clonal complex 11 lineage 11.2 clade as an effective urogenital pathogen.新克隆群 11 谱系 11.2 分支作为一种有效的泌尿生殖道病原体出现。
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4237-4242. doi: 10.1073/pnas.1620971114. Epub 2017 Apr 3.
7
WGS to predict antibiotic MICs for Neisseria gonorrhoeae.全基因组测序用于预测淋病奈瑟菌的抗生素最低抑菌浓度。
J Antimicrob Chemother. 2017 Jul 1;72(7):1937-1947. doi: 10.1093/jac/dkx067.
8
Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains.用于抗菌药物耐药性的淋病奈瑟菌序列分型,一种用于追踪淋病奈瑟菌菌株全球传播的新型抗菌药物耐药性多位点分型方案。
J Clin Microbiol. 2017 May;55(5):1454-1468. doi: 10.1128/JCM.00100-17. Epub 2017 Feb 22.
9
The new Korean action plan for containment of antimicrobial resistance.韩国遏制抗微生物药物耐药性新行动计划。
J Glob Antimicrob Resist. 2017 Mar;8:70-73. doi: 10.1016/j.jgar.2016.10.013. Epub 2016 Dec 23.
10
China's national plan to combat antimicrobial resistance.中国抗击抗菌药物耐药性国家计划。
Lancet Infect Dis. 2016 Nov;16(11):1216-1218. doi: 10.1016/S1473-3099(16)30388-7.